Market open
Anebulo Pharmaceuticals/$ANEB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Anebulo Pharmaceuticals
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
Ticker
$ANEB
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
3
Website
ANEB Metrics
BasicAdvanced
$40M
-
-$0.29
-1.16
-
Price and volume
Market cap
$40M
Beta
-1.16
52-week high
$2.19
52-week low
$0.80
Average daily volume
45K
Financial strength
Current ratio
17.519
Quick ratio
17.102
Interest coverage (TTM)
-33.52%
Management effectiveness
Return on assets (TTM)
-42.87%
Return on equity (TTM)
-71.49%
Valuation
Price to book
2.68
Price to tangible book (TTM)
2.68
Price to free cash flow (TTM)
-3.86
Growth
Earnings per share change (TTM)
-28.69%
3-year earnings per share growth (CAGR)
-48.59%
What the Analysts think about ANEB
Analyst Ratings
Majority rating from 3 analysts.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Anebulo Pharmaceuticals stock?
Anebulo Pharmaceuticals (ANEB) has a market cap of $40M as of April 14, 2025.
What is the P/E ratio for Anebulo Pharmaceuticals stock?
The price to earnings (P/E) ratio for Anebulo Pharmaceuticals (ANEB) stock is 0 as of April 14, 2025.
Does Anebulo Pharmaceuticals stock pay dividends?
No, Anebulo Pharmaceuticals (ANEB) stock does not pay dividends to its shareholders as of April 14, 2025.
When is the next Anebulo Pharmaceuticals dividend payment date?
Anebulo Pharmaceuticals (ANEB) stock does not pay dividends to its shareholders.
What is the beta indicator for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals (ANEB) has a beta rating of -1.16. This means that it has an inverse relation to market volatility.
